The existence of dual inner ear pathology such as unilateral Meniere’s disease (MD) with a contralateral vestibular schwannoma (VS) is very rare, but provides the otologist with a significant management dilemma. In this study, we present 5 cases of unilateral disabling MD with a contralateral VS in the better hearing ear. Conservative management of the VS is mandated unless there are impending complications, with management directed toward controlling the vertigo attributed to MD. If and when the VS requires intervention, or the hearing in that ear deteriorates to unserviceable levels, cochlear implant of the ear affected by MD prior to addressing the VS provides optimal management.

Keywords:
Meniere’s disease, Intratympanic gentamicin, Vestibular schwannoma
1.
Arts HA, Telian SA, El-Kashlan H, et al: Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach. Otol Neurotol 2006;27:234–241.
2.
Brackmann DE, Owens RM, Friedman RA, et al: Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 2000;21:417–424.
3.
Committee on Hearing and Equilibrium: Guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngol Head Neck Surg 1995;113:181–185.
4.
De Stefano A, Dispenza F, De Donato G, Caruso A, Taibah A, Sanna M: Intratympanic gentamicin: a one day protocol treatment for unilateral Meniere’s disease. Am J Otolaryngol 2007, in press.
5.
Driscoll CLW, Jackler RK, Pitts LH, Brackmann DE: Lesions of the internal auditory canal and cerebellopontine angle in a only hearing ear: is surgery ever advisable? Am J Otol 2000;21:573–581.
6.
Flint D, Fagan P, Panarese A: Conservative management of sporadic unilateral acoustic neuromas. J Laryngol Otol 2005;119:424–428.
7.
Gates GA: Meniere’s disease: medical therapy; in Harris JP (ed): Meniere’s disease. The Hague, Kugler Publications, 1999, pp 329–340.
8.
Khrais T, Sanna M: Hearing preservation in vestibular schwannoma. J Laryngol Otol 2006;120:366–370.
9.
Kobayashi T, Aslan A, Chiba T, Takasaka T, Sanna M: Measurement of endocochlear DC potentials in ears with acoustic neuromas: a preliminary report. Acta Otolaryngol 1996;116:791–795.
10.
Kondziolka D, Nathoo N, Flickinger JC, et al: Long-term results after radiosurgery for benign intracranial tumors. Neurosurgery 2003;53:815–822.
11.
Lange G: Die intratympanale Behandlung des Morbus Meniere mit ototoxischen Antibiotika. Z Laryngol 1977;56:409–414.
12.
Lin VY, Stewart C, Grebenyuk J, et al: Unilateral acoustic neuromas: long-term hearing results in patients managed with fractionated stereotactic radiotherapy, hearing preservation surgery, and expectantly. Laryngoscope 2005;115:292–296.
13.
Lustig LR, Yeagle J, Niparko JK, Minor LB: Cochlear implantation in patients with bilateral Meniere’s syndrome. Otol Neurotol 2003;24:397–403.
14.
McDaniel AB, Silverstein H: The treatment of acoustic neuroma and Meniere’s disease in the same patient. Otolaryngol Head Neck Surg 1987;96:39–42.
15.
Meyer TA, Canty PA, Wilkinson EP, et al: Small acoustic neuromas: surgical outcomes versus observation or radiation. Otol Neurotol 2006;27:380–392.
16.
Morgan M, Flood L, Hawthorne M, Raje S: Chemical labyrinthectomy and cochlear implantation for Meniere’s disease – an effective treatment or a last resort? J Laryngol Otol 1999;113:666–669.
17.
Naguib M, Saleh E, Aristegui M, Mazzoni A, Sanna M: Decision making in acoustic neuroma management: the only hearing ear. Skull Base Surg 1994;4:43–47.
18.
Ramsden R, Khwaja S, Green K, O’Driscoll M, Mawman D: Vestibular schwannoma in the only hearing ear: cochlear implant or auditory brainstem implant? Otol Neurotol 2005;26:261–264.
19.
Raut VV, Walsh RM, Bath AP, et al: Conservative management of vestibular schwannomas – second review of a prospective longitudinal study. Clin Otolaryngol 2004;29:505–514.
20.
Regis J, Delsanti Ch, Roche P, et al: Preservation of hearing function in radiosurgical treatment of unilateral vestibular schwannomas. Preliminary results. Neurochirurgie 2002;48:471–478.
21.
Rohit, Piccirillo E, Jain Y, et al: Preoperative predictive factors for hearing preservation in vestibular schwannoma surgery. Ann Otol Rhinol Laryngol 2006;115:41–46.
22.
Rosenberg SI: Natural history of acoustic neuromas. Laryngoscope 2000;110:497–508.
23.
Shojaku H, Watanabe Y, Mizukoshi K, et al: Epidemiological study of severe cases of Meniere’s disease in Japan. Acta Otolaryngol Suppl 1995;520:415–418.
24.
Smouha EE, Yoo M, Mohr K, et al: Conservative management of acoustic neuroma: a meta-analisys and proposed treatment algorithm. Laryngoscope 2005;115:450–454.
25.
Stahle J: Advanced Meniere’s disease. A study of 356 severely disabled patients. Acta Otolaryngol 1976;81:113–119.
26.
Stangerup SE, Caye-Thomasen P, Tos M, et al: The natural history of vestibular schwannoma. Otol Neurotol 2006;27:547–552.
27.
Suga F, Lindsay JR: Inner ear degeneration in acoustic neurinoma. Ann Otol Rhinol Laryngol 1976;85:343–358.
28.
Talbot A, Tonkin J, Fagan P, et al: Vestibular schwannoma in an only hearing ear. J Laryngol Otol 1994;108:983–985.
29.
Thedinger BA, Cueva RA, Glasscock ME 3rd: Treatment of an acoustic neuroma in an only-hearing ear: case reports and considerations for the future. Laryngoscope 1993;103:976–980.
30.
Tschudi DC, Linder TE, Fisch U: Conservative management of unilateral acoustic neuromas. Am J Otol 2000;21:722–728.
31.
Unger F, Walch C, Papaefthymiou G, et al: Radiosurgery of residual and recurrent vestibular schwannomas. Acta Neurochir 2002;144:671–676.
32.
Wareing MJ, O’Connor AF: The role of labyrinthectomy and cochlear implantation in Meniere’s disease. Ear Nose Throat J 1997;76:664–666, 668, 671–672.
33.
Warrick P, Bance M, Rutka J: The risk of hearing loss in nongrowing, conservatively managed acoustic neuromas. Am J Otol 1999;20:758–762.
34.
Zwolan TA, Shepard NT, Niparko JK: Labyrinthectomy with cochlear implantation. Am J Otol 1993;14:220–223.
© 2008 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.